rs41283431
Variant names:
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2
The NM_199334.5(THRA):c.738C>T(p.Asp246Asp) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,593,706 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0043 ( 16 hom. )
Consequence
THRA
NM_199334.5 synonymous
NM_199334.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 2.13
Publications
1 publications found
Genes affected
THRA (HGNC:11796): (thyroid hormone receptor alpha) The protein encoded by this gene is a nuclear hormone receptor for triiodothyronine. It is one of the several receptors for thyroid hormone, and has been shown to mediate the biological activities of thyroid hormone. Knockout studies in mice suggest that the different receptors, while having certain extent of redundancy, may mediate different functions of thyroid hormone. Alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq, Jul 2008]
THRA Gene-Disease associations (from GenCC):
- congenital nongoitrous hypothyroidism 6Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -17 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 17-40088256-C-T is Benign according to our data. Variant chr17-40088256-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259021.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=2.13 with no splicing effect.
BS2
High AC in GnomAd4 at 486 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 487AN: 152220Hom.: 1 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
487
AN:
152220
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00351 AC: 832AN: 236908 AF XY: 0.00352 show subpopulations
GnomAD2 exomes
AF:
AC:
832
AN:
236908
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00430 AC: 6203AN: 1441368Hom.: 16 Cov.: 32 AF XY: 0.00423 AC XY: 3025AN XY: 714408 show subpopulations
GnomAD4 exome
AF:
AC:
6203
AN:
1441368
Hom.:
Cov.:
32
AF XY:
AC XY:
3025
AN XY:
714408
show subpopulations
African (AFR)
AF:
AC:
19
AN:
33202
American (AMR)
AF:
AC:
101
AN:
43506
Ashkenazi Jewish (ASJ)
AF:
AC:
27
AN:
24530
East Asian (EAS)
AF:
AC:
1
AN:
39476
South Asian (SAS)
AF:
AC:
28
AN:
83060
European-Finnish (FIN)
AF:
AC:
374
AN:
52572
Middle Eastern (MID)
AF:
AC:
79
AN:
5680
European-Non Finnish (NFE)
AF:
AC:
5330
AN:
1099828
Other (OTH)
AF:
AC:
244
AN:
59514
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
360
719
1079
1438
1798
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
206
412
618
824
1030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00319 AC: 486AN: 152338Hom.: 1 Cov.: 31 AF XY: 0.00293 AC XY: 218AN XY: 74500 show subpopulations
GnomAD4 genome
AF:
AC:
486
AN:
152338
Hom.:
Cov.:
31
AF XY:
AC XY:
218
AN XY:
74500
show subpopulations
African (AFR)
AF:
AC:
24
AN:
41582
American (AMR)
AF:
AC:
59
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
AC:
5
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5182
South Asian (SAS)
AF:
AC:
1
AN:
4828
European-Finnish (FIN)
AF:
AC:
80
AN:
10618
Middle Eastern (MID)
AF:
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
AC:
307
AN:
68032
Other (OTH)
AF:
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
23
46
68
91
114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
THRA: BP4, BS2 -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.